Chojnacka K, Witek-Krowiak A, Skrzypczak D, Mikula K, Młynarz P
Department of Advanced Material Technologies, Faculty of Chemistry, Wrocław University of Science and Technology, Smoluchowskiego 25, 50-372 Wrocław, Poland.
Department of Biochemistry, Molecular Biology and Biotechnology, Faculty of Chemistry, Wrocław University of Science and Technology, Wyb. S. Wyspiańskiego 27, 50-370 Wrocław, Poland.
J Funct Foods. 2020 Oct;73:104146. doi: 10.1016/j.jff.2020.104146. Epub 2020 Jul 30.
The outbreak of Covid-19 disease caused by SARS-CoV-19, along with the lack of targeted medicaments and vaccines, forced the scientific world to search for new antiviral formulations. In this review, we describe the current knowledge about plant extracts containing polyphenols that inhibit Covid-19. Many plant-derived natural compounds (polyphenols) might provide a starting point for the research on the use of plant extracts in coronavirus treatment and prevention. Antivirus polyphenolic drugs can inhibit coronavirus enzymes, which are essential for virus replication and infection. This group of natural substances (betulinic acid, indigo, aloeemodine, luteolin, and quinomethyl triterpenoids, quercitin or gallates) is a potential key to designing antiviral therapies for inhibiting viral proteases. The known pharmacophore structures of bioactive substances can be useful in the elaboration of new anti-Covid-19 formulations. The benefit of using preparations containing phytochemicals is their high safety for patients and no side effects.
由SARS-CoV-19引起的新型冠状病毒肺炎疫情,加上缺乏针对性的药物和疫苗,迫使科学界寻找新的抗病毒制剂。在本综述中,我们描述了目前关于含多酚植物提取物抑制新型冠状病毒肺炎的知识。许多植物源天然化合物(多酚)可能为研究植物提取物在冠状病毒治疗和预防中的应用提供一个起点。抗病毒多酚药物可以抑制对病毒复制和感染至关重要的冠状病毒酶。这类天然物质(桦木酸、靛蓝、芦荟大黄素、木犀草素、喹甲基三萜、槲皮素或没食子酸盐)是设计抑制病毒蛋白酶的抗病毒疗法的潜在关键。生物活性物质已知的药效团结构可用于研发新的抗新型冠状病毒肺炎制剂。使用含有植物化学物质的制剂的好处是对患者安全性高且无副作用。